SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ixia of Class Action Lawsuit and Upcoming Deadline -- XXIA

NEW YORK, Nov. 30, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Ixia ("Ixia" or the "Company") (Nasdaq: XXIA ) and certain of its officers. The class action, filed in United States District Court, Central District of California, and docketed under 2:13-cv-8440, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired IXIA securities between April 29, 2010 and October 24, 2013 both dates inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

If you are a shareholder who purchased Ixia securities during the Class Period, you have until January 14, 2014 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

Ixia delivers information technology solutions to a wide variety of organizations, through real-time monitoring, real-world testing, and rapid assessment of networks and systems. The Company's tools are purportedly used to provide "end-to-end visibility" and complete understanding into user behavior, security vulnerabilities, network capacity, application performance, and IT resiliency.

Throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company improperly recognized revenues related to its warranty and software maintenance contracts; (2) The Company's Chief Executive Officer "CEO" misstated his academic credentials and employment history; (3) the Company lacked adequate internal and financial controls; and (4) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.

On March 19, 2013, Ixia announced that it had filed a Form 12b-25 with the SEC relating to the Company's Annual Report on Form 10-K for the year ended December 31, 2012, and that the Company needed to delay the filing of its Annual Report, "to correct an error related to the manner in which [Ixia] recognizes revenues for its warranty and software maintenance contracts."

On April 3, 2013, Ixia announced that after a further evaluation of the Company's finances, and identifying an additional error in the Company's revenue recognition practices that required correction, the Company's management recommended to the audit committee of the Company that the Company restate previously issued financial statements for the fiscal years ended December 31, 2011 and 2010, and the fiscal quarters ended March 31, 2011, June 30, 2011, September 30, 2011, March 31, 2012, June 30, 2012, and September 30, 2012 (the, "Restated Periods"); and, that the financial statements from the Restated Periods should no longer be relied upon. On this news, the Company's shares declined $1.94 per share, or over 9.5%, to close on April 4, 2013, at $18.37 per share.

On October 24, 2013, the Company disclosed "Vic Alston has resigned as its President and CEO and as a member of its board of directors following a determination by the Ixia audit committee that although he had attended Stanford University, he had misstated his academic credentials, incorrectly claiming to have received a B.S. and a M.S. in Computer Science, and had misstated his age and early employment history." On this news, the Company's shares declined $0.78 per share, or nearly 5%, to close on October 25, 2013, at $14.94 per share.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com .

Robert S. Willoughby Pomerantz Grossman Hufford Dahlstrom & Gross LLP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geothermal Energy Gets Boost with GRMS Adoption

Updated Category News Views 0

Geothermal's Big Leap with the GRMS The oil and gas sector didn't explode overnight—it leapt due to a consistent, standardized language that spoke to investors like a charm. Now, the geothermal industry is borrowing a page from this book of success with the Geothermal Resources Management System (GRMS). Finally, a framework not just built on hope and hot air, but...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 0

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
Mastering Power Efficiency with Phase Converters

Updated Category News Views 1

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
First Student Reduces Collisions by 63% with HALO Tech

Updated Category News Views 13

Making Every School Bus Ride Safer Here's some good news in the world of transportation, especially if you're keen on keeping kids safe on the daily school bus run. First Student's HALO™ Connected Transportation Platform claims it made a significant dent in reducing accidents—specifically, a 63% cut in forward collision risk. It's a big promise when you're talking...

Continue Reading
VIVIFY and ELISIUM Plan Hydrogen-Powered City

Updated Category News Views 1

Hydrogen Takes Center Stage in Urban Planning Well, I didn't see this one coming—a city that's planning the power before the buildings. We're talking about ELISIUM, the so-called cognitive city destined to rise in Hendry County, Florida. And leading the charge in all this energy planning? None other than VIVIFY Technology, set to bring in its hydrogen expertise right...

Continue Reading
New JPA Aims to Energize Inland Empire's Water Supply

Updated Category News Views 28

Fresh Steps in San Bernardino's Infrastructure Strategy Here's a twist for you: public agencies in San Bernardino County decided enough with the same old, same old and cooked up a new joint powers authority (JPA). They call it the San Bernardino Water and Power Authority, which sounds snappy enough for a meeting room nameplate, I reckon. Who's Steering the Ship? Leading...

Continue Reading
Plata Hits $1 Billion ARR in Record Digital Bank Growth

Updated Category News Views 14

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Continue Reading
Honeywell Aerospace Faces Securities Fraud Lawsuit

Updated Category News Views 11

Turning Up the Heat on Honeywell Alright, strap in because things are getting tense over at Honeywell Aerospace (NASDAQ:HONA). Schall, Brown & Schwartz LLP (SBS) is stirring the pot with a class action lawsuit alleging some pretty deceptive business going-ons. From securities violations to misleading market statements, they aren’t holding back any punches. What’s This...

Continue Reading
Roof Inspections: Richmond's Key to Home Longevity

Updated Category News Views 17

Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...

Continue Reading
Ryan Stills: Vegan Powerlifter Defies Odds, Wins Sixth World Title

Updated Category News Views 12

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Continue Reading

Top 5 Most Recently Viewed Articles

Children’s Place Sees Stock Surge Post Impressive Q2 Results

Updated Category News Views 56

Children’s Place Stock Rises After Strong Q2 Earnings Children’s Place, Inc. (NASDAQ: PLCE) has recently attracted a lot of attention as its stock prices soared following the release of its second-quarter earnings. The positive results came as a welcome surprise just before the market opened, leading to a notable increase in trading volumes. Strong Earnings Exceed...

Continue Reading
Yunji Inc. Confirms Compliance with Nasdaq Standards

Updated Category News Views 61

Yunji Inc. (NASDAQ: YJ) made headlines recently after confirming it had regained compliance with Nasdaq standards, signaling a significant recovery from non-compliance issues that had threatened its standing on the exchange. Compliance Rollercoaster: From Non-Compliance to Recovery Backtracking a bit, Yunji faced a stark reality when it was flagged by Nasdaq under Listing...

Continue Reading
Ladybug Nutratech Drives Revenue Growth with Strategic Plans

Updated Category News Views 43

Ladybug Nutratech Unleashes Revenue Growth Initiatives Ladybug Resource Group, Inc. (OTC PINK: LBRG), now known as Ladybug Nutratech, is swiftly positioning itself as a frontrunner in the health and wellness sector. The company has demonstrated an impressive revenue growth of $6.0 million, which reflects an extraordinary increase of 10,527% compared to the same timeline...

Continue Reading
New Findings Show Duvakitug's Efficacy for Inflammatory Bowel Disease

Updated Category News Views 87

Groundbreaking Results from the Duvakitug Study Teva Pharmaceuticals Industries Ltd. (NYSE: TEVA) and Sanofi SA (NASDAQ: SNY) have recently unveiled promising data from their RELIEVE UCCD Phase 2b study involving duvakitug, a new treatment for moderate-to-severe ulcerative colitis (UC) and Crohn’s disease (CD), two prevalent types of inflammatory bowel disease (IBD)....

Continue Reading
Caliway's Innovative Weight Management Drug CBL-514 Advances Development

Updated Category News Views 126

Caliway's CBL-514 is Primed for Phase 2 Clinical Trial Caliway has recently completed its submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA). This submission is critical as it paves the way for a Phase 2 clinical study focusing on weight management using CBL-514, an innovative drug candidate designed to address...

Continue Reading